These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26530057)

  • 1. Basing approval of drugs for type 2 diabetes on real world outcomes.
    McGovern A; Hinchliffe R; Munro N; de Lusignan S
    BMJ; 2015 Nov; 351():h5829. PubMed ID: 26530057
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking the appraisal and approval of drugs for type 2 diabetes.
    Naci H; Lehman R; Wouters OJ; Goldacre B; Yudkin JS
    BMJ; 2015 Oct; 351():h5260. PubMed ID: 26452524
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosiglitazone: a case of regulatory hubris.
    Nissen SE
    BMJ; 2013 Dec; 347():f7428. PubMed ID: 24335808
    [No Abstract]   [Full Text] [Related]  

  • 4. US FDA approves three new drugs for Type 2 diabetes.
    Bond T
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):101. PubMed ID: 23593719
    [No Abstract]   [Full Text] [Related]  

  • 5. A voyage of discovery.
    Gebel E
    Diabetes Forecast; 2013 Jun; 66(6):50-3. PubMed ID: 23802293
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticipated US approval for rosiglitazone and pioglitazone.
    Diabetes Obes Metab; 1999 May; 1(3):181-2. PubMed ID: 11220298
    [No Abstract]   [Full Text] [Related]  

  • 7. European Medicines Agency: Approval of new glucose-lowering medicines for type 2 diabetes.
    Bailey CJ
    Diabetes Obes Metab; 2018 Sep; 20(9):2057-2058. PubMed ID: 29756322
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel diabetes drugs to face higher hurdles?
    Opar A
    Nat Rev Drug Discov; 2007 Sep; 6(9):687-9. PubMed ID: 17907340
    [No Abstract]   [Full Text] [Related]  

  • 9. New treatments for diabetes.
    Irony I; Parks MH; Meyer RJ
    N Engl J Med; 2007 May; 356(21):2221; author reply 2222-3. PubMed ID: 17526095
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
    Misbin RI
    Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatments for diabetes.
    Raz I; Eldor R
    N Engl J Med; 2007 May; 356(21):2222; author reply 2222-3. PubMed ID: 17526096
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin and antidiabetic agents -- the old and the new.
    Golembiewski J
    J Perianesth Nurs; 2006 Apr; 21(2):131-4. PubMed ID: 16600835
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the cardiovascular safety of diabetes therapies.
    Goldfine AB
    N Engl J Med; 2008 Sep; 359(11):1092-5. PubMed ID: 18784098
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the Safety of Glucose-Lowering Drugs - A New Focus for the FDA.
    Chong WH; Yanoff LB; Andraca-Carrera E; Thanh Hai M
    N Engl J Med; 2020 Sep; 383(13):1199-1202. PubMed ID: 32966719
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
    Gorman C
    Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric drug development programs for type 2 diabetes: A review.
    Christensen ML; Franklin BE; Momper JD; Reed MD
    J Clin Pharmacol; 2015 Jul; 55(7):731-8. PubMed ID: 25781151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic safety of incretin-based drugs--FDA and EMA assessment.
    Egan AG; Blind E; Dunder K; de Graeff PA; Hummer BT; Bourcier T; Rosebraugh C
    N Engl J Med; 2014 Feb; 370(9):794-7. PubMed ID: 24571751
    [No Abstract]   [Full Text] [Related]  

  • 18. The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
    Califf RM; Kramer JM
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):782-6. PubMed ID: 18655016
    [No Abstract]   [Full Text] [Related]  

  • 19. Finding new treatments for diabetes--how many, how fast... how good?
    Nathan DM
    N Engl J Med; 2007 Feb; 356(5):437-40. PubMed ID: 17267901
    [No Abstract]   [Full Text] [Related]  

  • 20. Meeting of the minds: Send your stories.
    Albaugh JF; Haywood JR; Jefferies JA; Yatagai T
    Science; 2015 Jul; 349(6244):148-9. PubMed ID: 26160935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.